Erik D. Roberson

Advocate Lutheran General Hospital — United States

Medicine · Health Sciences

78h-index31.7kcitations322works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(143), Dementia and Cognitive Impairment Research(83), Amyotrophic Lateral Sclerosis Research(63), Parkinson's Disease Mechanisms and Treatments(43), Functional Brain Connectivity Studies(35)

Publications256 total

Female Informants are associated with higher CDR PLUS NACC‐FTLD scores in patients with Frontotemporal Dementia
Alzheimer s & Dementia·2025Open Access
Developing and validating normed scores for cognitive dispersion among older adults
Alzheimer s & Dementia·2025Open Access
Sex Differences in Neuropsychiatric Symptoms Associated with Agitation in Frontotemporal Lobar Degeneration
Alzheimer s & Dementia·2025Open Access
Variations in the Effect of Pulse Pressure on Cognition Based on Blood Pressure
2025Open Access
A study of patient recall and comprehension of genetic testing results in amyotrophic lateral sclerosis (ALS)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration·2025
Estimation of reference curves for brain atrophy and analysis of robustness to machine effects
Scientific Reports·2025Open Access
TREM2‐apoE3 interactions and Alzheimer's disease: Molecular and structural insights and effects of TREM2 R47H and apoE4 variants
Alzheimer s & Dementia·2025· 1 citedOpen Access
Surface-based morphometry reveals divergent aging trajectories in veterans with and without traumatic brain injury
GeroScience·2025Open Access
Functional Connectivity Associations With Markers of Disease Progression in <i>GRN</i> Pathogenic Variant Carriers
Annals of Clinical and Translational Neurology·2025Open Access
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology
Alzheimer s & Dementia·2025· 2 citedOpen Access
Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration
Nature Aging·2025Open Access
Reduction of sphingomyelinase activity associated with progranulin deficiency and frontotemporal dementia
Neurobiology of Disease·2025· 1 citedOpen Access
Assessing Social Dominance in Mouse Models Using the Tube Test
Journal of Visualized Experiments·2025
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease
Acta Neuropathologica·2025· 3 citedOpen Access
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration
Nature Aging·2025· 7 citedOpen Access
Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia
Alzheimer s & Dementia·2025· 5 citedOpen Access
Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial
The Lancet Neurology·2025· 27 cited
Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders
Molecular Neurodegeneration·2025· 15 citedOpen Access
Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia
Alzheimer s & Dementia·2024· 1 citedOpen Access
X‐chromosome-wide association study for Alzheimer’s disease
Molecular Psychiatry·2024· 6 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Bruce L. Miller(16), Adam L. Boxer(11), Lennart Mucke(9), David S. Knopman(9), Irene Litvan(9), J. David Sweatt(6), Howard J. Rosen(6), Rachelle S. Doody(6), Lawrence S. Honig(6), Ging‐Yuek Robin Hsiung(6), Clifford R. Jack(6), Joel H. Kramer(6), Murray Grossman(6), Hilary W. Heuer(6), Bradford C. Dickerson(6), Daniel Kaufer(6), Jorge J. Palop(5), Mario F. Mendez(5), John C. Morris(5), Chiadi U. Onyike(5)